PGD in the lab for triplet repeat diseases - myotonic dystrophy, Huntington's disease and Fragile-X syndrome.

Sara Seneca, Andre Van Steirteghem, Martine De Rycke, Anick De Vos, Veerle Goossens, Ingeborg Liebaers, Karen Sermon, Willy Lissens, Hilde Van De Velde, Anna Ferraretti (Editor), Luca Gianaroli (Editor), Cristini Magli (Editor), Peter Platteau, Joe Simpson (Editor), Yury Verlinsky (Editor)

Research output: Contribution to journalMeeting abstract (Journal)

68 Citations (Scopus)

Abstract

Myotonic dystrophy (DM), Huntington's disease (HD) and Fragile X syndrome (FRAXA) are three monogenic disease which are caused by so-called dynamic mutations. These mutations are caused by triplet repeats inside or in the vicinity of the gene which have the tendency to expand beyond the normal range thus disrupting the normal functioning of the gene. We describe here our experiences from 1995 to May 2000 with PGD for these three triplet repeat diseases.
Original languageEnglish
Pages (from-to)77-85
Number of pages9
JournalMol Cell Endocrinol
Volume183
Issue numberOctober
Publication statusPublished - Oct 2001
EventUnknown -
Duration: 1 Oct 2001 → …

Bibliographical note

Mol Cell Endocrinol, 183 suppl 1, S77-85., 2001.

Keywords

  • dynamic mutations

Fingerprint

Dive into the research topics of 'PGD in the lab for triplet repeat diseases - myotonic dystrophy, Huntington's disease and Fragile-X syndrome.'. Together they form a unique fingerprint.

Cite this